Add to My Favorites Login | Join Us Now

More than just an annual gathering,

IBS provides the professional platform sharing the most cutting-edge technologies in global biopharmaceutical industry.

Aiming at helping industry players to:

> Achieve insights of the regulatory for Biopharm in China
> Build up strategic partnership with global leading biopharmas and research organizations
> Learn from in-depth case studies on how to develop effective and low-cost products
> Leverage advanced key technologies in drug R&D and process development
> Implement high quality biopharm large scale manufacturing

Contact us Now

Tel: +86 21 60527081

Register to Conference
Gain Free Access to the System


Weiguo Dai

Technical Director, Johnson & Johnson
Shoubai Chao

Senior VP, Technology and Manufacturing, Astrazeneca China
Chen Dong

Professor, Tsinghua University School of Medicine
Shun Luo

President, JS Bioscience; Former R&D director of Amgen
Joe Zhou

CEO, Genor Biopharma
Racho Jordanov

President, JHL Biotech
Jianwei Zhu

Chair Professor, Shanghai Jiaotong University
Rolf G.Werner

Professor of Tuebingen University, Germany; Former VP of Biopharma Devision in Boehringer Ingelheim
Chris Chen

Senior VP, Biopharma CTO, Wuxi Apptec

Dimiter Dimitrov

Professor, NIH

Yu Xia

CEO, Akesobio; Former R&D Director, Abbott
Peng Liang

Founder, President Clover Biopharmaceuticals

Who Will Attend:

> Officers from drug regulatory agencies
> Scientists and professors from leading research institutes and colleges
> Senior management from antibody drug manufacturers
> Senior management from protein drug manufacturers
> Senior management from polypeptide drug manufacturers
> Senior management from Genetic engineering drug manufacturers
> Senior management from vaccine manufacturers
> Senior management from blood products manufacturers
See Who Attends

Key Figures:

1 top three biopharma industrial park in China
18 featured speakers
40 top services providers exhibiting
250 attendees from leading biopharmas and research organizations
20000 visitors in to the exhibition area

Why sponsoring or exhibiting in IBS 2014?

> Direct contact with 250+ decision makers and qualified buyers
> Direct visited by 20000+ visitors in biopharmaceutical industry
> Position your products and services as key players in front of major industry leaders
> Provide multiple opportunities to communicate directly with your target audience before and after the conference through specific social media portals and event sites
> Deliver your sales message in a bold new way, boosting your customer acquisition and lead generation strategies through tailor-made and creative branding packages